Aehr Test Systems (AEHR)
8.80 x 17 8.98 x 1
Post-market by (Cboe BZX)
8.90 -0.06 (-0.67%) 03/21/25 [NASDAQ]
8.80 x 17 8.98 x 1
Post-market 8.88 -0.02 (-0.22%) 16:29 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
05-2024 | 05-2023 | 05-2022 | 05-2021 | 05-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 33,156 | 14,557 | 9,450 | -2,027 | -2,802 |
Depreciation Amortization | 1,363 | 1,099 | 1,045 | 328 | 384 |
Income taxes - deferred | -20,773 | N/A | N/A | N/A | N/A |
Accounts receivable | 6,790 | -3,788 | -7,834 | -1,373 | 1,161 |
Accounts payable and accrued liabilities | -3,891 | 5,044 | 1,356 | 1,877 | -1,024 |
Other Working Capital | -14,378 | -7,841 | -10,295 | 298 | -561 |
Other Operating Activity | -511 | 940 | 7,786 | -1,804 | 818 |
Operating Cash Flow | $1,756 | $10,011 | $1,508 | $-2,701 | $-2,024 |
Cash Flows From Investing Activities | |||||
PPE Investments | -749 | -1,362 | -416 | -227 | -163 |
Purchase Of Investment | N/A | -33,294 | N/A | N/A | N/A |
Sale Of Investment | 18,000 | 16,000 | N/A | N/A | N/A |
Investing Cash Flow | $17,251 | $-18,656 | $-416 | $-227 | $-163 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | 1,400 | N/A |
Debt Issued | N/A | N/A | N/A | N/A | 1,679 |
Common Stock Issued | 1,735 | 9,382 | 27,590 | 560 | 493 |
Common Stock Repurchased | -1,596 | -2,060 | -429 | N/A | N/A |
Other Financing Activity | 0 | 0 | -1,400 | 0 | 0 |
Financing Cash Flow | $139 | $7,322 | $25,761 | $1,960 | $2,172 |
Exchange Rate Effect | -41 | -37 | 49 | 117 | 20 |
Beginning Cash Position | 30,204 | 31,564 | 4,662 | 5,513 | 5,508 |
End Cash Position | 49,309 | 30,204 | 31,564 | 4,662 | 5,513 |
Net Cash Flow | $19,105 | $-1,360 | $26,902 | $-851 | $5 |
Free Cash Flow | |||||
Operating Cash Flow | 1,756 | 10,011 | 1,508 | -2,701 | -2,024 |
Capital Expenditure | -749 | -1,362 | -416 | -227 | -163 |
Free Cash Flow | 1,007 | 8,649 | 1,092 | -2,928 | -2,187 |